Clinical Trial Update: Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating the combination of atezolizumab and cabozantinib in patients with metastatic, refractory pancreatic cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• cabozantinib (cabozantinib)

Snippet

Sponsor: University of Arizona | Conditions: Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING